Cerebral Palsy

Neurology·MeSH: Cerebral Palsy

6 drugs in development·2 companies·13 clinical trials

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
Scopoderm® patches arm	Revance Therapeutics, Inc. (RVNC)

Phase 2(1)

Drug	Company
Conditioned Medium	Accustem Sciences Inc. (ACUT)

Phase 1(1)

Drug	Company
Umbilical Cord Mesenchymal Stem Cells	Accustem Sciences Inc. (ACUT)

Phase 4(3)

Drug	Company
Botox® injection	Revance Therapeutics, Inc. (RVNC)
onabotulinumtoxin A	Revance Therapeutics, Inc. (RVNC)
OnabotulinumtoxinA	Revance Therapeutics, Inc. (RVNC)

BioSniper tracks 6 drugs in development for Cerebral Palsy across 2 companies.

There are 13 clinical trials targeting Cerebral Palsy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.